| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525200 Multicyclic aromatic compounds and uses thereof |
| 02/25/2003 | US6525196 5HT1 antagonists for antidepressant therapy |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases |
| 02/25/2003 | US6525064 Immune response modifiers; can induce the biosynthesis of various cytokines; |
| 02/25/2003 | US6525063 3,7-dimethyl-1,5-diazaanthraquinone for example |
| 02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
| 02/25/2003 | US6525056 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders |
| 02/25/2003 | US6525049 Pyrroloquinolones as antiviral agents |
| 02/25/2003 | US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine; |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6525044 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome. |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6524761 Photosensitive with respect to light from the visible to near infrared range; charging; electrostatic stability; mass spectrophotometry |
| 02/25/2003 | CA2073747C Process for the continuous preparation of perylenetetracarboxylic diimides |
| 02/20/2003 | WO2003014128A2 Tumour inhibiting cerium compounds |
| 02/20/2003 | WO2003014121A1 Compounds, derivatives, compositions, preparation and uses |
| 02/20/2003 | WO2003014120A1 Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| 02/20/2003 | WO2003014119A1 Tricyclic epoxides |
| 02/20/2003 | WO2003014118A1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES |
| 02/20/2003 | WO2003014117A1 3-substituted pyrrolo[2.1-a]isoquinoline derivatives |
| 02/20/2003 | WO2003014116A1 Pyrrolo[2.1-a]isoquinoline derivatives |
| 02/20/2003 | WO2003014115A1 3-substituted pyrrolo (2.1-a) isoquinoline derivatives |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003014075A2 Novel gamma secretase inhibitors |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002078602A3 Transdermal delivery of pergolide |
| 02/20/2003 | WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/20/2003 | WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | US20030036651 As phosphodiesterase inhibitor for prophylaxis and therapy of bronchial asthma; pneumonic diseases, pulmonary emphysema, chronic obstructive pulmonary disease acute respiratory distress syndrome (ARDS), and other respiratory diseases |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036542 Derivatives of pyrimido[6.1-a]isoquinolin-4-one |
| 02/20/2003 | US20030036473 Catalysts and methods for catalytic oxidation |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2456550A1 Tumour inhibiting cerium compounds |
| 02/20/2003 | CA2453537A1 Therapeutic 1h-pyrido¬4,3-b|indoles |
| 02/20/2003 | CA2452802A1 Tricyclic epoxides |
| 02/19/2003 | EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 02/19/2003 | EP1283836A2 Neuroprotective and anti-proliferative compounds |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 02/19/2003 | EP0988302B1 Benzonaphthyridines |
| 02/19/2003 | EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1397557A NOvel octahydro-2H-pyridino-[1,2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 02/19/2003 | CN1397551A N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide |
| 02/19/2003 | CN1397549A Novel derivative of 2-azadicyclo-(2,2,1) heptane, its prepn. and use |
| 02/19/2003 | CN1101649C Herbicidal synergistic compsn. and method of controlling weeds |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521656 Contacting sperm with a pyrazolo(1,5-a)pyridine acrosomal reaction induction promoter then joining with ovum |
| 02/18/2003 | US6521638 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 02/18/2003 | US6521636 Imidazo-pyridines as corticotropin releasing factor antagonists |
| 02/18/2003 | US6521629 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
| 02/18/2003 | US6521623 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/18/2003 | US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/18/2003 | US6521592 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2003 | WO2003011864A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 02/13/2003 | WO2003011862A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/13/2003 | WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 02/13/2003 | WO2003011824A1 Bicyclic modulators of androgen receptor function |
| 02/13/2003 | WO2003011450A1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof |
| 02/13/2003 | WO2003011297A1 N3-substituted 6-anilinopyrimidines and methods to treat gram-positive bacterial and mycoplasmal infections |
| 02/13/2003 | WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| 02/13/2003 | WO2003011264A2 Betacarboline derivatives as gaba a-receptor-modulators having nmda-antagonistic activity for treating diseases of the central nervous system |
| 02/13/2003 | WO2002087574A3 Use of pyridoindolone derivatives for preparing anticancer medicines |
| 02/13/2003 | WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds |
| 02/13/2003 | WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002037927A3 Compounds and methods for promoting smoking cessation |
| 02/13/2003 | WO2001072754A8 Alkylated imidazopyridine derivatives |
| 02/13/2003 | US20030032805 Process for the preparation of high purity pemirolast |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
| 02/13/2003 | US20030028975 For dyeing hair |
| 02/12/2003 | EP1282732A1 Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282621A1 Novel vitronectin receptor antagonists |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282404A2 Method for preparing microparticles having a selected polymer molecular weight |
| 02/12/2003 | EP0947514B1 Novel phenanethridinium derivatives |
| 02/12/2003 | EP0816338B1 3-(bis-substituted-phenylmethylene)oxindole derivatives |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396165A Zilpaterol hydrochcoride monohydrate |
| 02/11/2003 | US6518426 Pyrimidine derivatives and methods of making and using these derivatives |
| 02/11/2003 | US6518297 Selective 5-HT6 receptor ligands |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518280 Antiviral and antitumor properties; immunomodulators and for inducing cytokine biosynthesis in animals |
| 02/11/2003 | US6518276 Treating a p38 mediated disorders |
| 02/11/2003 | US6518271 1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
| 02/11/2003 | US6518270 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |